CSP
6 min read
11

Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU

December 10, 2024
0

Reading Time: 4 minutes Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase 3 study using 8 weeks of daily dosing followed by weekly maintenance dosing. The company’s focus going forward will be on the effective

Continue Reading
CSP
2 min read
16

The Swedish Financial Supervisory Authority has approved TF Bank’s transfer of a majority stake in the subsidiary Rediem Capital AB

December 10, 2024
0

Reading Time: 2 minutes On 4 October 2024, TF Bank AB (publ) (”TF Bank” or the ”Bank”) announced that the Bank entered into a share purchase agreement (the “Share Purchase Agreement”) with Alektum Holding AB (publ) (”Alektum Holding”) and Erik Selin Fastigheter Aktiebolag (”Erik Selin

Continue Reading
CSP
1 min read
21

Participation in warrant exercise by Curasight management

December 10, 2024
0

Reading Time: < 1 minute Copenhagen, Denmark, 10 December 2024 – Curasight A/S (“Curasight” or the “Company” – TICKER: CURAS) hereby announces in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, the disclosure of participation by members of Curasight’s Board

Continue Reading
CSP
2 min read
13

Buy-back of shares in MTG during week 49, 2024

December 10, 2024
0

Reading Time: 2 minutes During the period between 2 December and 6 December 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 90,547 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.

Continue Reading
CSP
1 min read
7

Fondia Plc: Share repurchase 10.12.2024

December 10, 2024
0

Reading Time: < 1 minute Fondia Plc Company release 10.12.2024 at 6.45 p.m. EET   Fondia – Acquisition of own shares 10.12.2024   Fondia Plc   First North Finland   Date 10.12.2024 Exchange transactions Buy Share class FONDIA Amount, shares 688 Average price/share, EUR 4,917616

Continue Reading
CSP
3 min read
11

Zwipe AS – Subscription of new shares in the Company by exercise of subscription rights in the Rights Issue by primary insider

December 10, 2024
0

Reading Time: 2 minutes OSLO, NORWAY – 10 December 2024 – Reference is made to the stock exchange announcement published by Zwipe AS (the “Company“) on 6 December 2024, regarding the commencement of the subscription period in a new issue of units (the “Units“), consisting

Continue Reading
CSP
4 min read
10

Eco Wave Power Announces Pricing of $3.0 Million Registered Direct Offering to Propel Commercial-Scale Wave Energy Deployment

December 10, 2024
0

Reading Time: 3 minutes Tel Aviv, Israel (December 10, 2024) – Eco Wave Power Global AB (publ) (Nasdaq: WAVE) (“Eco Wave Power” or the “Company”), a leading innovator in onshore wave energy technology, today announced that it has entered into a securities purchase agreement with a

Continue Reading
CSP
2 min read
10

STENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com

December 10, 2024
0

Reading Time: 2 minutes STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO Stenocare has announced its STENOCARE 3.0 strategy, unveiled on November 26, which marks a bold new chapter in its mission to become a leader in the medical cannabis industry. This transformative strategy positions Stenocare

Continue Reading
STL Digital Drives Vedanta’s Digital Transformation with RISE with SAP
BWI
4 min read
27

STL Digital Drives Vedanta’s Digital Transformation with RISE with SAP

December 10, 2024
0

Reading Time: 3 minutes   Bengaluru, Karnataka, India:  STL Digital Limited, an IT Services and Consulting Company [a wholly-owned subsidiary of STL (NSE: STLTECH)], announces the successful deployment of RISE with SAP S/4HANA Cloud for eight Vedanta companies (Hindustan Zinc Ltd., Sterlite Copper, Cairn Oil &

Continue Reading
CSP
4 min read
8

Correction: EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals

December 10, 2024
0

Reading Time: 3 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT. EQL

Continue Reading